Literature DB >> 32557927

Overview of biological effects of Quercetin on ovary.

Zahra Rashidi1, Zahra Khosravizadeh2, Ali Talebi3,4, Kajal Khodamoradi2, Reyhane Ebrahimi5,6, Fardin Amidi2,4,7.   

Abstract

Over the last few decades, using natural products has been increased to treat different diseases. Today, great attention has been pointed toward the usage of natural products such as flavonoids, especially Quercetin (QUR), in the treatment of diseases. QUR as a natural antioxidant has been traditionally used to prevent or treat a variety of diseases such as cancer, cardiovascular disease, polycystic ovary syndrome (PCOS), obesity, chronic inflammation, and reproductive system dysfunction. Several studies demonstrated that QUR acts as an anti-inflammatory, anti-apoptotic, antioxidant, and anticancer agent. With this in view, in this study, we intended to describe an overview of the biological effects of QUR on the ovary. QUR improves the quality of oocytes and embryos. It affects the proliferation and apoptosis and decreases the oxidative stress in granulosa cells (GCs). Furthermore, QUR can be used as a complementary and alternative therapy in ovarian cancer and it has beneficial effects in the treatment of PCOS patients. It seems that QUR as a supplementary factor has different activities for the treatment of different disorders and it also has bidirectional activities. However, further investigations are needed for understanding the efficacy of QUR in the treatment and improvement of gynecological patients.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Granulosa cell; oocyte; ovarian cancer; polycystic ovary syndrome; quercetin

Year:  2020        PMID: 32557927     DOI: 10.1002/ptr.6750

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  7 in total

1.  Effects of Fagonia indica on Letrozole-Induced Polycystic Ovarian Syndrome (PCOS) in Young Adult Female Rats.

Authors:  Anam Younas; Liaqat Hussain; Arham Shabbir; Muhammad Asif; Musaddique Hussain; Faiza Manzoor
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-26       Impact factor: 2.650

Review 2.  Exosomes as Biomarkers for Female Reproductive Diseases Diagnosis and Therapy.

Authors:  Sahar Esfandyari; Hoda Elkafas; Rishi Man Chugh; Hang-Soo Park; Antonia Navarro; Ayman Al-Hendy
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

Review 3.  The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches.

Authors:  Narges Zafari; Fatemeh Khosravi; Zahra Rezaee; Sahar Esfandyari; Mohamad Bahiraei; Afshin Bahramy; Gordon A Ferns; Amir Avan
Journal:  J Clin Lab Anal       Date:  2022-07-08       Impact factor: 3.124

Review 4.  The role of Sirtuin 1 in the pathophysiology of polycystic ovary syndrome.

Authors:  Mali Wu; Jie Zhang; Ran Gu; Fangfang Dai; Dongyong Yang; Yajing Zheng; Wei Tan; Yifan Jia; Bingshu Li; Yanxiang Cheng
Journal:  Eur J Med Res       Date:  2022-08-27       Impact factor: 4.981

5.  Rhamnocitrin decreases fibrosis of ovarian granulosa cells by regulating the activation of the PPARγ/NF-κB/TGF-β1/Smad2/3 signaling pathway mediated by Wisp2.

Authors:  Yan-Yuan Zhou; Chun-Hua He; Huan Lan; Zhe-Wen Dong; Ya-Qi Wu; Jia-Le Song
Journal:  Ann Transl Med       Date:  2022-07

6.  Simulation studies, 3D QSAR and molecular docking on a point mutation of protein kinase B with flavonoids targeting ovarian Cancer.

Authors:  Suchitra Maheswari Ajjarapu; Apoorv Tiwari; Gohar Taj; Dev Bukhsh Singh; Sakshi Singh; Sundip Kumar
Journal:  BMC Pharmacol Toxicol       Date:  2021-11-02       Impact factor: 2.483

7.  The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.

Authors:  Meng Li; Wenqi Zhang; Linqi Yang; Huibing Wang; Yihan Wang; Kai Huang; Wei Zhang
Journal:  Dis Markers       Date:  2021-06-29       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.